Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection

Veterinary Immunology and Immunopathology

Volumn 139, Issue 2-4, 2011, Pages 128-140

  Adams, Amanda A ^a   Sturgill, Tracy L ^a   Breathnach, Cormac C ^a   Chambers, Thomas M ^a   Siger, Leonardo ^b   Minke, Jules M ^b   Horohov, David W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Aging; Equine influenza virus; Immunosenescence; Vaccination

Indexed keywords

CD5 ANTIGEN; EQUINE INFLUENZA VIRUS VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIVE VACCINE; MESSENGER RNA; RECOMBINANT VACCINE; RECOMBITEK; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VECTOR;

AGED; ANIMAL CELL; ANOREXIA; ANTIBODY TITER; ARTICLE; BODY TEMPERATURE; CANARYPOX VIRUS; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COUGHING; CYTOKINE PRODUCTION; DEPRESSION; DYSPNEA; EQUINE INFLUENZA; EQUINE INFLUENZA VIRUS; FEVER; GENE EXPRESSION; HORSE; HUMORAL IMMUNITY; INFECTION SENSITIVITY; INFLUENZA VIRUS; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RECTUM TEMPERATURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINORRHEA; SINGLE DRUG DOSE; T LYMPHOCYTE; VIRUS SHEDDING;

AGING; ANIMALS; CANARYPOX VIRUS; HORSE DISEASES; HORSES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, SYNTHETIC;

CANARYPOX VIRUS; EQUIDAE; EQUINE INFLUENZA VIRUS;

EID: 78650895471     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.09.006     Document Type: Article

References (74)

1. Adams A.A., Breathnach C.C., Katepalli M.P., Kohler K., Horohov D.W. Advanced age in horses affects divisional history of T cells and inflammatory cytokine production. Mech. Ageing. Dev. 2008, 129:656-664.
2. Adams A.A., Katepalli M.P., Kohler K., Reedy S.E., Stilz J.P., Vick M.M., Fitzgerald B.P., Lawrence L.M., Horohov D.W. Effect of body condition, body weight and adiposity on inflammatory cytokine responses in old horses. Vet. Immunol. Immunopathol. 2009, 127:286-294.
3. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Wurzner R., Schonitzer D., Grubeck-Loebenstein B. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 2005, 79:3675-3683.
4. Bernstein E.D., Gardner E.M., Abrutyn E., Gross P., Murasko D.M. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 1998, 16:1722-1731.
5. Boon A.C., Fringuelli E., Graus Y.M., Fouchier R.A., Sintnicolaas K., Iorio A.M., Rimmelzwaan G.F., Osterhaus A.D. Influenza A virus specific T cell immunity in humans during aging. Virology 2002, 299:100-108.
6. Bot A., Bot S., Bona C.A. Protective role of gamma interferon during the recall response to influenza virus. J. Virol. 1998, 72:6637-6645.
7. Breathnach C.C., Rudersdorf R., Lunn D.P. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination. Vet. Immunol. Immunopathol. 2004, 98:127-136.
8. Breathnach C.C., Soboll G., Suresh M., Lunn D.P. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets. Vet. Immunol. Immunopathol. 2005, 103:207-215.
9. Breathnach C.C., Clark H.J., Clark R.C., Olsen C.W., Townsend H.G., Lunn D.P. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine 2006, 24:1180-1190.
10. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., Horohov D.W. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 2006, 112:199-209.
11. Brydak L.B., Machala M., Mysliwska J., Mysliwski A., Trzonkowski P. Immune response to influenza vaccination in an elderly population. J. Clin. Immunol. 2003, 23:214-222.
12. Deng Y., Jing Y., Campbell A.E., Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J. Immunol. 2004, 172:3437-3446.
13. Effros R.B. Costimulatory mechanisms in the elderly. Vaccine 2000, 18:1661-1665.
14. Effros R.B. Long-term immunological memory against viruses. Mech. Ageing Dev. 2000, 121:161-171.
15. Effros R.B. Problems and solutions to the development of vaccines in the elderly. Immunol. Allergy Clin. North Am. 2003, 23:41-55.
16. Fagiolo U., Amadori A., Cozzi E., Bendo R., Lama M., Douglas A., Palu G. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging (Milano) 1993, 5:451-458.
17. Fagnoni F.F., Vescovini R., Passeri G., Bologna G., Pedrazzoni M., Lavagetto G., Casti A., Franceschi C., Passeri M., Sansoni P. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000, 95:2860-2868.
18. Fermaglich D.H., Horohov D.W. The effect of aging on immune responses. Vet. Clin. North Am. Equine Pract. 2002, 18. 621-630, ix.
19. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 2000, 908:244-254.
20. Gardner E.M., Gonzalez E.W., Nogusa S., Murasko D.M. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine 2006, 24:1609-1614.
21. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
22. Goronzy J.J., Weyand C.M. T cell development and receptor diversity during aging. Curr. Opin. Immunol. 2005, 17:468-475.
23. Goto H., Yamamoto Y., Ohta C., Shirahata T., Higuchi T., Ohishi H. Antibody responses of Japanese horses to influenza viruses in the past few years. J. Vet. Med. Sci. 1993, 55:33-37.
24. Hannant D., Mumford J.A. Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells. Vet. Immunol. Immunopathol. 1989, 21:327-337.
25. Hannant D., Jessett D.M., O'Neill T., Mumford J.A. Antibody isotype responses in the serum and respiratory tract to primary and secondary infections with equine influenza virus (H3N8). Vet. Microbiol. 1989, 19:293-303.
26. Horohov D.W., Dimock A., Guirnalda P., Folsom R.W., McKeever K.H., Malinowski K. Effect of exercise on the immune response of young and old horses. Am. J. Vet. Res. 1999, 60:643-647.
27. Horohov D.W., Adams A.A., Chambers T.M. Immunosenescence of the equine immune system. J. Comp. Pathol. 2010, 142(Suppl. 1):S78-84.
28. Johnson B.J., Costelloe E.O., Fitzpatrick D.R., Haanen J.B., Schumacher T.N., Brown L.E., Kelso A. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2657-2662.
29. Kang I., Hong M.S., Nolasco H., Park S.H., Dan J.M., Choi J.Y., Craft J. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J. Immunol. 2004, 173:673-681.
30. Laver W.G., Valentine R.C. Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 1969, 38:105-119.
31. Lazuardi L., Jenewein B., Wolf A.M., Pfister G., Tzankov A., Grubeck-Loebenstein B. Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 2005, 114:37-43.
32. Lewis M.J., Wagner B., Woof J.M. The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies. Mol. Immunol. 2008, 45:818-827.
33. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
34. Lunn D.P., Holmes M.A., Duffus W.P. Three monoclonal antibodies identifying antigens on all equine T lymphocytes, and two mutually exclusive T-lymphocyte subsets. Immunology 1991, 74:251-257.
35. Lunn D.P., Holmes M.A., Antczak D.F., Agerwal N., Baker J., Bendali-Ahcene S., Blanchard-Channell M., Byrne K.M., Cannizzo K., Davis W., Hamilton M.J., Hannant D., Kondo T., Kydd J.H., Monier M.C., Moore P.F., O'Neil T., Schram B.R., Sheoran A., Stott J.L., Sugiura T., Vagnoni K.E. Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995. Vet. Immunol. Immunopathol. 1998, 62:101-143.
36. Lunn D., Soboll G., Schram B., Quass J., McGregor M., Drape R., Macklin M., McCabe D., Swain W., Olsen C. Antibody response to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 1999, 17:2245-2258.
37. Lunn D.P., Soboll G., Schram B.R., Quass J., McGregor M.W., Drape R.J., Macklin M.D., McCabe D.E., Swain W.F., Olsen C.W. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 1999, 17:2245-2258.
38. McElhaney J.E. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 2005, 23(Suppl. 1):S10-25.
39. McElhaney J.E., Beattie B.L., Devine R., Grynoch R., Toth E.L., Bleackley R.C. Age-related decline in interleukin 2 production in response to influenza vaccine. J. Am. Geriatr. Soc. 1990, 38:652-658.
40. McElhaney J.E., Hooton J.W., Hooton N., Bleackley R.C. Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 2005, 23:3294-3300.
41. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 2006, 176:6333-6339.
42. McFarlane D., Sellon D.C., Gibbs S.A. Age-related quantitative alterations in lymphocyte subsets and immunoglobulin isotypes in healthy horses. Am. J. Vet. Res. 2001, 62:1413-1417.
43. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 1983, 309:13-17.
44. Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., Jessett D., Black L., Bublot M., Pardo M.C., Audonnet J.C. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Am. J. Vet. Res. 2008, 68:213-219.
45. Minke J.M., Toulemonde C.E., Dinic S., Cozette V., Cullinane A., Audonnet J.C. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine. J. Comp. Pathol. 2008, 137(Suppl. 1):S76-80.
46. Morley P.S., Townsend H.G., Bogdan J.R., Haines D.M. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J. Am. Vet. Med. Assoc. 1999, 215:61-66.
47. Moss P. Cellular immune responses to influenza. Dev. Biol. (Basel) 2003, 115:31-37.
48. Muirhead T.L., McClure J.T., Wichtel J.J., Stryhn H., Markham R.J., McFarlane D., Lunn D.P. The effect of age on the immune response of horses to vaccination. J. Comp. Pathol. 2010, 142(Suppl. 1):S85-90.
49. Mumford J.A., Wood J. Establishing an acceptability threshold for equine influenza vaccines. Dev. Biol. Stand 1992, 79:137-146.
50. Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp. Gerontol. 2002, 37:427-439.
51. Nelson K.M., Schram B.R., McGregor M.W., Sheoran A.S., Olsen C.W., Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 1998, 16:1306-1313.
52. Newton J.R., Townsend H.G., Wood J.L., Sinclair R., Hannant D., Mumford J.A. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet. J. 2000, 32:65-74.
53. Newton J.R., Daly J.M., Spencer L., Mumford J.A. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet. Rec. 2006, 158:185-192.
54. OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2008, vols. 1 & 2. Office International des Epizooties, Paris, 1413 p. 6th ed.
55. Ouyang Q., Cicek G., Westendorp R.G., Cools H.J., van der Klis R.J., Remarque E.J. Reduced IFN-gamma production in elderly people following in vitro stimulation with influenza vaccine and endotoxin. Mech. Ageing Dev. 2000, 121:131-137.
56. Paillot R., Hannant D., Kydd J.H., Daly J.M. Vaccination against equine influenza: Quid novi?. Vaccine 2006.
57. Paillot R., Kydd J.H., Sindle T., Hannant D., Edlund Toulemonde C., Audonnet J.C., Minke J.M., Daly J.M. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet. Immunol. Immunopathol. 2006, 112:225-233.
58. Paillot R., Kydd J.H., MacRae S., Minke J.M., Hannant D., Daly J.M. New assays to measure equine influenza virus-specific Type 1 immunity in horses. Vaccine 2007, 25:7385-7398.
59. Patterson-Kane J.C., Carrick J.B., Axon J.E., Wilkie I., Begg A.P. The pathology of bronchointerstitial pneumonia in young foals associated with the first outbreak of equine influenza in Australia. Equine Vet. J. 2008, 40:199-203.
60. Poulet H., Minke J., Pardo M.C., Juillard V., Nordgren B., Audonnet J.C. Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform. Vaccine 2007, 25:5606-5612.
61. Powers D.C. Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age. J. Am. Geriatr. Soc. 1993, 41:1-5.
62. Quinlivan M., Zamarin D., Garcia-Sastre A., Cullinane A., Chambers T., Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 2005, 79:8431-8439.
63. Quinlivan M., Nelly M., Prendergast M., Breathnach C., Horohov D., Arkins S., Chiang Y.W., Chu H.J., Ng T., Cullinane A. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. Vaccine 2007, 25:7056-7064.
64. Saurwein-Teissl M., Steger M.M., Gluck R., Cryz S., Grubeck-Loebenstein B. Influenza vaccination in a healthy geriatric population: preferential induction of antibodies specific for the H3N2 influenza strain despite equal T cell responsiveness to all vaccine strains. Vaccine 1998, 16:196-200.
65. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., Parson W., Bock G., Schonitzer D., Trannoy E., Grubeck-Loebenstein B. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 2002, 168:5893-5899.
66. Slater J., Hannant D. Equine immunity to viruses. Vet. Clin. North Am. Equine Pract. 2000, 16:49-68.
67. Soboll G., Horohov D.W., Aldridge B.M., Olsen C.W., McGregor M.W., Drape R.J., Macklin M.D., Swain W.F., Lunn D.P. Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet. Immunol. Immunopathol. 2003, 94:47-62.
68. Spiegelberg H.L. Biological activities of immunoglobulins of different classes and subclasses. Adv. Immunol. 1974, 19:259-294.
69. Stepanova L., Naykhin A., Kolmskog C., Jonson G., Barantceva I., Bichurina M., Kubar O., Linde A. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. J. Clin. Virol. 2002, 24:193-201.
70. Toulemonde E.C., Daly J., Sindle T., Guigal P.M., Audonnet J.C., Minke J.M. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet. Rec. 2005, 156:367-371.
71. Traub-Dargatz J.L., Salman M.D., Voss J.L. Medical problems of adult horses, as ranked by equine practitioners. J. Am. Vet. Med. Assoc. 1991, 198:1745-1747.
72. Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20:1831-1836.
73. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992, 56:152-179.
74. Weinberger B., Herndler-Brandstetter D., Schwanninger A., Weiskopf D., Grubeck-Loebenstein B. Biology of immune responses to vaccines in elderly persons. Clin. Infect. Dis. 2008, 46:1078-1084.